This is a snippet of the transcript, sign up to read more.
HashiCorp recently changed their licensing model strategically, around the same time Red Hat was altering Santos. This led to less backlash from the community. There's a concerted effort at HashiCorp, led by individuals like Nick Calver, to create value sales. The goal is to show organizations the value they're getting from HashiCorp, encouraging them to increase their investments rather than look elsewhere.
This is a snippet of the transcript, sign up to read more.
I believe when Susan comes in, she will demand results. She will expect everyone to meet their targets. It will take her a couple of quarters to realize that every sales leader is trying to meet their targets. The problem is that there are people on their teams who shouldn't be there, and it's very difficult to let someone go when they shouldn't be there.
This is a snippet of the transcript, sign up to read more.
As for HashiCorp, there are a few aspects to consider. The products were more or less identical, but with the new licensing, this will no longer be the case. This is a positive development for HashiCorp and for those selling HashiCorp. The key to selling HashiCorp or any enterprise product, or any supported open-source product, is to engage the right people. From my experience, the users have less influence than they might want us to believe.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research